{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:36:17Z","timestamp":1791426977096,"version":"4.3.3"},"reference-count":0,"publisher":"American Public Health Association","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Public Health"],"published-print":{"date-parts":[[2013,8]]},"abstract":"<jats:p>At the beginning of the 1960s, it was clear that a vaccine against measles would soon be available. Although measles was (and remains) a killer disease in the developing world, in the United States and Western Europe this was no longer so. Many parents and many medical practitioners considered measles an inevitable stage of a child\u2019s development. Debating the desirability of measles immunization, public health experts reasoned differently. In the United States, introduction of the vaccine fit well with Kennedy\u2019s and Johnson\u2019s administrations\u2019 political commitments. European policymakers proceeded cautiously, concerned about the acceptability of existing vaccination programs. In Sweden and the Netherlands, recent experience in controlling polio led researchers to prefer an inactivated virus vaccine. Although in the early 1970s attempts to develop a sufficiently potent inactivated vaccine were abandoned, we have argued that the debates and initiatives of the time during the vaccine\u2019s early history merit reflection in today\u2019s era of standardization and global markets.<\/jats:p>","DOI":"10.2105\/ajph.2012.301075","type":"journal-article","created":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T15:59:17Z","timestamp":1371139157000},"page":"1393-1401","source":"Crossref","is-referenced-by-count":42,"title":["Measles Vaccination Before the Measles-Mumps-Rubella Vaccine"],"prefix":"10.2105","volume":"103","author":[{"given":"Jan","family":"Hendriks","sequence":"first","affiliation":[{"name":"Jan Hendriks is with International Support, Vaccinology Unit, National Institute of Public Health and the Environment, Bilthoven, the Netherlands. Stuart Blume is with the Department of Sociology and Anthropology, University of Amsterdam, Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Blume","sequence":"additional","affiliation":[{"name":"Jan Hendriks is with International Support, Vaccinology Unit, National Institute of Public Health and the Environment, Bilthoven, the Netherlands. Stuart Blume is with the Department of Sociology and Anthropology, University of Amsterdam, Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"844","container-title":["American Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ajph.aphapublications.org\/doi\/pdf\/10.2105\/AJPH.2012.301075","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T19:21:16Z","timestamp":1652124076000},"score":1,"resource":{"primary":{"URL":"https:\/\/ajph.aphapublications.org\/doi\/full\/10.2105\/AJPH.2012.301075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["10.2105\/AJPH.2012.301075"],"URL":"https:\/\/doi.org\/10.2105\/ajph.2012.301075","relation":{},"ISSN":["0090-0036","1541-0048"],"issn-type":[{"value":"0090-0036","type":"print"},{"value":"1541-0048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}